A retrospective study of clinicopathologic and molecular features of inoperable early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy
Open Access
- 1 December 2021
- journal article
- research article
- Published by Elsevier in Journal of the Formosan Medical Association
- Vol. 120 (12) , 2176-2185
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortalityBritish Journal of Cancer, 2012
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningNew England Journal of Medicine, 2011
- Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung CancerJAMA, 2010
- Outcomes After Stereotactic Lung Radiotherapy or Wedge Resection for Stage I Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2010
- Co-morbidity index predicts for mortality after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancerRadiotherapy and Oncology, 2009
- Stage I nonsmall cell lung cancer in patients aged ≥75 yearsCancer, 2009
- Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study GroupsJournal of Clinical Oncology, 2008
- Age‐adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancerCancer, 2008
- A note on competing risks in survival data analysisBritish Journal of Cancer, 2004
- Racial Differences in the Treatment of Early-Stage Lung CancerNew England Journal of Medicine, 1999